what to expect on retatrutide UK Guide: Key Facts the New Weight-Loss Drug Retatrutide UK 2026: Phase 3

MASH is increasingly being recognized as the leading indication for liver transplant listing for women and is expected to overtake ALD as the leading liver transplant indication for all patients within the next few years (60, 63)

This condition is known as cerebral folate deficiency, and has been implicated as a reversible cause of autism

You should not use this medication if you have a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

In fact, prunes contain a mix of both insoluble and soluble fiber that simultaneously add bulk to the stool while helping it move quickly through the gut

doi:10.1530/raf-20-0037 Salvio G, Cutini M, Ciarloni A, Giovannini L, Perrone M, Balercia G